ReviewMetabolites2025
SGLT2 Inhibitors: Multifaceted Therapeutic Agents in Cardiometabolic and Renal Diseases.
Ana Checa-Ros et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it
ReviewMetabolites2025
Ana Checa-Ros et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.